Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 8.58%52.77B | 10.76%14.06B | 14.24%13.72B | 5.42%13.88B | 3.55%11.11B | -0.94%48.6B | 5.04%12.69B | -3.64%12.01B | 7.59%13.17B | -12.58%10.73B |
Cost of revenue | 2.47%43.06B | 1.58%11.06B | 4.52%10.86B | 2.22%11.59B | 1.55%9.55B | 4.39%42.02B | 7.86%10.89B | 0.38%10.39B | 14.06%11.34B | -4.70%9.4B |
Gross profit | 47.56%9.71B | 66.12%3B | 76.62%2.86B | 25.19%2.29B | 17.76%1.57B | -25.27%6.58B | -9.27%1.81B | -23.31%1.62B | -20.39%1.83B | -44.84%1.33B |
Operating expense | -1.79%5.34B | 13.58%1.37B | 6.25%1.48B | -19.27%1.13B | -5.41%1.36B | -5.81%5.44B | -6.85%1.21B | -18.43%1.39B | -4.01%1.4B | 9.67%1.43B |
Staff costs | -2.43%2.87B | 1.70%740.33M | -1.64%720.96M | -5.29%687.36M | -4.44%719.44M | -0.43%2.94B | -3.30%727.99M | -3.17%732.98M | -3.08%725.76M | 8.52%752.84M |
Selling and administrative expenses | -34.09%496.93M | -21.70%120.13M | -20.31%121.68M | -46.16%117.41M | -40.06%137.72M | -11.37%753.95M | 2.67%153.42M | -13.30%152.68M | -19.73%218.08M | -9.35%229.76M |
-General and administrative expense | -34.09%496.93M | -21.70%120.13M | -20.31%121.68M | -46.16%117.41M | -40.06%137.72M | -11.37%753.95M | 2.67%153.42M | -13.30%152.68M | -19.73%218.08M | -9.35%229.76M |
Depreciation and amortization | 18.67%426.56M | 8.78%122.69M | 16.16%106.14M | 20.65%100.4M | 35.04%97.33M | 41.69%359.46M | 61.16%112.79M | 53.91%91.38M | 31.58%83.22M | 17.99%72.07M |
-Depreciation | 18.67%426.56M | 8.78%122.69M | 16.16%106.14M | 20.65%100.4M | 35.04%97.33M | 41.69%359.46M | 61.16%112.79M | 53.91%91.38M | 31.58%83.22M | 17.99%72.07M |
Other operating expenses | 11.88%1.55B | 82.17%388.1M | 27.78%529.74M | -39.43%228.22M | 5.97%401.29M | -19.35%1.38B | -34.19%213.05M | -41.91%414.56M | -0.54%376.79M | 26.79%378.67M |
Operating profit | 281.55%4.37B | 172.21%1.63B | 507.86%1.38B | 171.76%1.16B | 300.80%209.39M | -62.24%1.15B | -13.80%597.88M | -43.87%227.1M | -49.05%425.84M | -109.46%-104.28M |
Net non-operating interest income (expenses) | 30.80%-46.56M | 48.17%-8.21M | 33.75%-10.46M | 23.34%-13.89M | 20.13%-14M | 33.23%-67.28M | 27.07%-15.84M | 32.25%-15.79M | 34.81%-18.12M | 37.26%-17.53M |
Non-operating interest income | 16.91%3.33M | -4.25%338K | -17.92%1.26M | 175.69%499K | 57.56%1.24M | 119.06%2.85M | 163.43%353K | 206.41%1.53M | 47.15%181K | 44.40%787K |
Non-operating interest expense | -28.86%49.89M | -47.22%8.55M | -32.35%11.72M | -21.37%14.39M | -16.79%15.24M | -31.29%70.13M | -25.91%16.19M | -27.25%17.32M | -34.45%18.3M | -35.70%18.32M |
Net investment income | 114.88%118.32M | 113.10%5.61M | 108.50%7.92M | -3,218.08%-43.87M | -22.70%148.66M | -47.47%55.07M | -140.06%-42.79M | -164.08%-93.14M | 98.59%-1.32M | 460.55%192.32M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 6,958.59%54.21M | -97.20%768K | ||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -1,963.23%-2.11B | -2,367.84%-2.06B | -678.01%-10.38M | -274.76%-39.95M | 173.67%7.08M | -166.83%-102.03M | -154.54%-83.55M | 112.45%1.8M | -1,416.50%-10.66M | -165.78%-9.62M |
Less:Impairment of capital assets | -46.49%10.43M | ---- | ---- | ---- | ---- | 23.14%19.48M | ---- | ---- | ---- | ---- |
Less:Other special charges | -86.74%3.24M | -100.40%-24K | 678.01%10.38M | -100.29%-31K | -173.67%-7.08M | 114.34%24.45M | 103.53%5.97M | -114.46%-1.8M | 1,416.50%10.66M | 165.78%9.62M |
Less:Write off | 3,500.21%2.09B | 3,431.38%2.05B | --0 | ---- | ---- | 2,754.55%58.09M | 200,210.34%58.09M | --0 | ---- | ---- |
Other non-operating income (expenses) | 343.56%47.77M | 99.29%-476K | -39.33%11.78M | 31.37%23.85M | 28.14%12.61M | -107.51%-19.61M | -144.51%-67.03M | 1,096.56%19.42M | 216.05%18.16M | -90.78%9.84M |
Income before tax | 141.08%2.44B | -198.40%-383.2M | 889.57%1.38B | 161.76%1.08B | 414.21%363.74M | -70.89%1.01B | -64.91%389.43M | -72.68%139.38M | -42.44%413.89M | -93.81%70.74M |
Income tax | 196.90%669.34M | 346.07%133.44M | 173.74%194.2M | 52.13%254.53M | 110.45%87.17M | -65.13%225.44M | -128.76%-54.23M | -61.23%70.94M | 6.81%167.31M | -65.02%41.42M |
Net income | 125.11%1.77B | -216.45%-516.64M | 1,631.53%1.19B | 236.15%828.88M | 843.44%276.57M | -72.21%788M | -51.84%443.66M | -79.09%68.44M | -56.16%246.58M | -97.14%29.32M |
Net income continuous operations | 125.11%1.77B | -216.45%-516.64M | 1,631.55%1.19B | 236.15%828.88M | 843.41%276.57M | -72.21%788M | -51.84%443.66M | -79.09%68.44M | -56.16%246.58M | -97.14%29.32M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 125.11%1.77B | -216.45%-516.64M | 1,631.53%1.19B | 236.15%828.88M | 843.44%276.57M | -72.21%788M | -51.84%443.66M | -79.09%68.44M | -56.16%246.58M | -97.14%29.32M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 125.11%1.77B | -216.45%-516.64M | 1,631.53%1.19B | 236.15%828.88M | 843.44%276.57M | -72.21%788M | -51.84%443.66M | -79.09%68.44M | -56.16%246.58M | -97.14%29.32M |
Gross dividend payment | ||||||||||
Basic earnings per share | 125.11%85.16 | -216.43%-24.8 | 1,634.45%56.89 | 236.06%39.79 | 841.84%13.28 | -72.21%37.83 | -51.84%21.3 | -79.12%3.28 | -56.15%11.84 | -97.13%1.41 |
Diluted earnings per share | 125.11%85.16 | -216.45%-24.8027 | 1,634.45%56.89 | 236.14%39.79 | 841.84%13.28 | -72.21%37.83 | -51.84%21.2982 | -79.12%3.28 | -56.16%11.8375 | -97.13%1.41 |
Dividend per share | 57.14%11 | 50.00%6 | 0 | 66.67%5 | 0 | 0.00%7 | 0.00%4 | 0 | 0.00%3 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |